Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T- lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA

International Journal of Cancer

Volumn 82, Issue 1, 1999, Pages 121-124

  Nair, Smita K ^a   Hull, Shelley ^a   Coleman, Doris ^a   Gilboa, Eli ^a   Lyerly, H Kim ^a   Morse, Michael A ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Box 2606 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD11 ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; INTERLEUKIN 4; PEPTIDE; RNA;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; METASTASIS; MONONUCLEAR CELL; PRIORITY JOURNAL; TARGET CELL;

CARCINOEMBRYONIC ANTIGEN; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY, ACTIVE; NEOPLASM METASTASIS; NEOPLASMS; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033516548     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990702)82:1<121::AID-IJC20>3.0.CO;2-X     Document Type: Article

References (16)

1. BANCHEREAU, J. and STEINMAN, R.M., Dendritic cells and the control of immunity. Nature (Lond.), 392, 245-252 (1998).
2. BENDER, A., SAPP, M., SCHULER, G., STEINMAN, R.M. and BHARDWAJ, N., Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods, 196, 121-135 (1996).
3. BOCZKOWSKI, D., NAIR, S., SNYDER, D. and GILBOA, E., Dendritic cells pulsed with RNA are potent antigen presenting cells in vitro and in vivo. J. exp. Med., 184, 465-472 (1996).
4. CELLUZZI, C.M., MAYORDOMO, J.I., STORKUS, W.J., LOTZE, M.T. and FALO, J.L.D., Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. exp. Med., 183,283-287 (1996).
5. FLAMAND, V., SORNASSE, T., THIELEMANS, K., DEMANET, C., BAKKUS, M., BAZIN, H., TIELEMANS, F., LEO, O., URBAIN, J. and MOSER, M., Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Europ. J. Immunol., 24, 605-610 (1994).
6. MAYORDOMO, J.I., ZORINA, T., STORKUS, W.J., ZITVOGEL, L., CELLUZZI, C., FALO, L.D., MELIEF, C.J., ILDSTAD, S.T., KAST, W.M., DELEO, A.B. and LOTZE, M.T., Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature (Med.), 12, 1297-1302 (1995).
7. MORSE, M.A. and LYERLY, H.K., Immunotherapy of cancer using dendritic cells. Cytokines cell. mol. Ther., 4, 35-44 (1998).
8. MORSE, M.A., ZHOU, L.J., TEDDER, T.F., LYERLY, H.K. and SMITH, C., Generation of dendritic cells in vitro from peripheral blood mononuclear cells with GM-CSF, IL-4, and TNF-α for use in cancer immunotherapy. Ann. Surg., 226, 6-16 (1997).
9. MURPHY, G., TJOA, B., RAGDE, H., KENNY, G. and BOYNTON, A., Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate, 29, 371-380 (1996).
10. NAIR, S.K., BOCZKOWSKI, D., MORSE, M.A., CUMMING, R.I., LYERLY, H.K. and GILBOA, E., Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature (Biotech.), 16, 364-369 (1998).
11. NESTLE, F.O., ALIJAGIC, S., GILLIET, M., SUN, Y., GRABBE, S., DUMMER, R., BURG, G. and SCHADENDORF, D., Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature (Med.), 4, 328-332 (1998).
12. PAGLIA, P., CHIODONI, C., RODOLFO, M. and COLOMBO, M.P., Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. exp. Med., 183, 317-322 (1996).
13. PORGADOR, A. and GILBOA, E., Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. exp. Med., 182, 255-260 (1995).
14. PORGADOR, A., SNYDER, D. and GILBOA, E., Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol., 156, 2918-2926 (1996).
15. ROMANI, N., REIDER, D., HEUER, M., EBNER, S., KAMPGEN, E., EIBL, B., NIEDERWIESER, D. and SCHULER, G., Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. immunol. Methods, 196, 137-151 (1996).
16. WONG, C., MORSE, M. and NAIR, S.K., Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides. J. Immunother., 21, 32-40 (1998).